Clinical Trial Update: Efficacy of Dorzolamide as an Adjuvant After Focal Photocoagulation in Clinically Significant Macular Edema

View source ↗

Summary

Clinical trial update evaluating dorzolamide as an adjuvant to focal photocoagulation in clinically significant macular edema due to diabetic retinopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema
• Diabetic Retinopathy

Drugs mentioned

• Dorzolamide (Dorzolamide)

Snippet

Sponsor: Hospital Juarez de Mexico | Conditions: Diabetic Retinopathy, Diabetic Macular Edema | Status: UNKNOWN